13.01

0.66% 0.085

After Hours: 12.80 -0.205 -1.58%

R 1 Rcm Inc (RCM)

Overview News Price History Option Chain Financials Why RCM Down? Discussions Forecast

R 1 Rcm Inc stock is traded at $13.01, with a volume of 1.68M. It is up +0.66% in the last 24 hours and up +3.30% over the past month. R1 RCM Inc is a provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers. Its services help healthcare providers generate sustainable improvements in their operating margins and cash flows while also enhancing patient, physician, and staff satisfaction for the customers, Its service offering consists of end-to-end RCM services for health systems, hospitals, and physician groups that provide comprehensive revenue cycle infrastructure to providers, including all revenue cycle personnel, technology solutions, and process workflow. The majority of the revenue comes from the operating fees received.

Previous Close:

$12.92

Open:

$13

24h Volume:

1.68M

Market Cap:

$5.48B

Revenue:

$2.31B

Net Income/Loss:

$-33.40M

P/E Ratio:

-151.57

EPS:

-0.0858

Net Cash Flow:

$228.60M

1W Performance:

-2.14%

1M Performance:

+3.30%

6M Performance:

+25.65%

1Y Performance:

-21.94%

1D Range:

$12.87

$13.09

52W Range:

$8.87

$18.54

R 1 Rcm Inc Stock (RCM) Company Profile

Name

R 1 Rcm Inc

Sector

Healthcare (1186)

Industry

Health Information Services (64)

Phone

(312) 324-7820

Address

434 W. ASCENSION WAY, 6TH FLOOR, MURRAY, IL

Employee

30,000

Twitter

@r1rcm

Next Earnings Date

2024-08-07

Latest SEC Filings

RCM's Discussions on Twitter

R 1 Rcm Inc Stock (RCM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-03-24	Initiated	Barclays	Overweight
Dec-15-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Dec-13-23	Downgrade	JP Morgan	Overweight → Neutral
Oct-19-23	Upgrade	Truist	Hold → Buy
Sep-22-23	Initiated	Citigroup	Buy
Aug-15-23	Initiated	Cantor Fitzgerald	Overweight
Apr-12-23	Initiated	Stephens	Overweight
Apr-11-23	Initiated	Robert W. Baird	Outperform
Feb-02-23	Downgrade	Truist	Buy → Hold
Jan-05-23	Initiated	Canaccord Genuity	Buy
Dec-07-22	Upgrade	Guggenheim	Neutral → Buy
Dec-06-22	Initiated	Morgan Stanley	Equal-Weight
Oct-24-22	Initiated	Evercore ISI	Outperform
Sep-16-22	Initiated	KeyBanc Capital Markets	Overweight
Sep-07-22	Initiated	Truist	Buy
Aug-01-22	Resumed	JP Morgan	Overweight
Jun-29-22	Resumed	Barclays	Overweight
Apr-14-22	Initiated	Guggenheim	Neutral
Feb-09-22	Initiated	Deutsche Bank	Buy
Dec-02-21	Initiated	Jefferies	Buy
Oct-14-21	Initiated	JP Morgan	Overweight
Sep-30-21	Initiated	Barclays	Overweight
Jul-22-21	Initiated	BofA Securities	Buy
Jun-02-21	Initiated	Robert W. Baird	Outperform
Aug-05-20	Upgrade	SVB Leerink	Mkt Perform → Outperform
Apr-21-20	Initiated	RBC Capital Mkts	Outperform
Apr-13-20	Initiated	SVB Leerink	Mkt Perform
Jan-14-20	Reiterated	Dougherty & Company	Buy
Jan-10-20	Initiated	Dougherty & Company	Buy
Jan-22-19	Initiated	KeyBanc Capital Mkts	Overweight
Dec-10-18	Initiated	Citigroup	Buy
Sep-04-18	Initiated	Chardan Capital Markets	Buy
Apr-09-18	Upgrade	Robert W. Baird	Neutral → Outperform